Skip to main content

Advisors Asset Management, Inc.

SEC CIK
0001297376
Latest filing
Aug 13, 2026

PFE holding history

Pfizer Inc in every 13F filed by Advisors Asset Management, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
873,428
Value
$21.0M
% of portfolio
0.3%
Quarters held
33
Since Q1 2018
Holdings of PFE by Advisors Asset Management, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026873,428$21.0M0.3%−7,845−0.9%ReducedHolders
Q1 2026881,273$24.7M0.4%−36,540−4.0%ReducedHolders
Q4 2025917,813$22.9M0.4%+49,486+5.7%AddedHolders
Q3 2025868,327$22.1M0.4%+39,989+4.8%AddedHolders
Q2 2025828,338$20.1M0.4%+23,633+2.9%AddedHolders
Q1 2025804,705$20.4M0.4%+56,237+7.5%AddedHolders
Q4 2024748,468$19.9M0.4%+59,283+8.6%AddedHolders
Q3 2024689,185$19.9M0.4%+28,704+4.3%AddedHolders
Q2 2024660,481$18.5M0.4%+4,544+0.7%AddedHolders
Q1 2024655,937$18.2M0.3%+78,352+13.6%AddedHolders
Q4 2023577,585$16.6M0.3%+13,008+2.3%AddedHolders
Q3 2023564,577$18.7M0.4%+15,507+2.8%AddedHolders
Q2 2023549,070$20.1M0.4%+25,522+4.9%AddedHolders
Q1 2023523,548$21.4M0.4%−10,623−2.0%ReducedHolders
Q4 2022534,171$27.4M0.6%+16,723+3.2%AddedHolders
Q3 2022517,448$22.6M0.5%−21,648−4.0%ReducedHolders
Q2 2022539,096$28.3M0.5%+539,096NewHolders
Q1 20220$00.0%−560,889−100.0%Sold outHolders
Q4 2021560,889$33.1M0.5%−20,238−3.5%ReducedHolders
Q3 2021581,127$25.0M0.4%−88,404−13.2%ReducedHolders
Q2 2021669,531$26.2M0.4%−151,995−18.5%ReducedHolders
Q1 2021821,526$29.8M0.5%−104,357−11.3%ReducedHolders
Q4 2020925,883$34.1M0.5%−181,022−16.4%Reduced–
Q3 20201,106,905$40.6M0.8%−61,668−5.3%Reduced–
Q2 20201,168,573$38.2M0.7%+22,438+2.0%Added–
Q1 20201,146,135$37.4M0.9%+90,940+8.6%Added–
Q4 20191,055,195$41.3M0.7%+5,625+0.5%Added–
Q3 20191,049,570$37.7M0.7%−87,465−7.7%Reduced–
Q2 20191,137,035$49.3M0.9%−130,629−10.3%Reduced–
Q1 20191,267,664$53.8M1.0%−145,393−10.3%Reduced–
Q4 20181,413,057$61.7M1.2%−196,252−12.2%Reduced–
Q3 20181,609,309$70.9M1.2%−32,310−2.0%Reduced–
Q2 20181,641,619$59.6M1.0%−117,206−6.7%Reduced–
Q1 20181,758,825$63.9M1.1%–––

Livermore's 13F data starts with Q1 2018, so Q1 2018 has no change from the previous quarter.